Evaluation of bone health within blood is a challenge. Vitamin D, PTH and bone turnover markers like P1NP and CTx are the most frequently used biomarkers. However, do all these biomarkers have true clinical value in the diagnosis and follow up of patients with bone (related) diseases? What are the analytical possibilities? Moreover, what unmet clinical needs exist in the field of biomarkers for bone health? And will we be able to fulfill these needs in the future in the laboratory?
These questions will be answered by national and international experts in the field.